Osteonecrosis of the jaws associated with the use of yearly zoledronic acid: report of 2 cases. (Q43746304)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21523843%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

title

Osteonecrosis of the jaws associated with the use of yearly zoledronic acid: report of 2 cases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21523843%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21523843%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Jiiang-Huei Jeng

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21523843%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Chun-Pin Chiang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21523843%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Jang-Jaer Lee

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21523843%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Sang-Heng Kok

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21523843%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

Yi-Ping Wang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21523843%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

26 April 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21523843%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21523843%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21523843%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21523843%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

E6-10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21523843%20AND%20SRC:MED&resulttype=core&format=json

Persistence with weekly alendronate therapy among postmenopausal women

29 January 2020

cites work

1 reference

Determinants of non-compliance with bisphosphonates in women with postmenopausal osteoporosis

21 January 2018

1 reference

Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis

21 January 2018

1 reference

A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics

21 January 2018

1 reference

Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis

21 January 2018

1 reference

American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update

21 January 2018

1 reference

Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment

21 January 2018

1 reference

Incidence of osteonecrosis of the jaw in women with postmenopausal osteoporosis in the health outcomes and reduced incidence with zoledronic acid once yearly pivotal fracture trial.

21 January 2018

1 reference

Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic

21 January 2018

1 reference

Bisphosphanates and Oral Cavity Avascular Bone Necrosis

21 January 2018

1 reference

Low incidence of osteonecrosis of the jaw in postmenopausal women with osteoporosis taking zoledronic acid once yearly

21 January 2018

1 reference

Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws

21 January 2018

1 reference

Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates

21 January 2018

1 reference

Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors

21 January 2018

1 reference

Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors.

21 January 2018

1 reference

Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment

21 January 2018

1 reference

Practical Guidelines for the Prevention, Diagnosis, and Treatment of Osteonecrosis of the Jaw in Patients With Cancer

21 January 2018

1 reference

Clinical investigation of C-terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws.

21 January 2018

1 reference

Intravenous zoledronic acid in postmenopausal women with low bone mineral density

21 January 2018

1 reference

Zoledronic acid for the prevention of bone loss in postmenopausal women with low bone mass: a randomized controlled trial

21 January 2018

1 reference

Transmission of human herpesvirus 8 by blood transfusion

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/HED.21758

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21523843%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference